Indian pharma companies better off than global peers: Moody's

Indian pharma companies better off than global peers:
According to Moody's, Indian pharma market is highly fragmented with the largest player accounting for 8.8% of the $12 to $15 billion market. Representational Image. Image Source: Pixabay

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x